These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13669755)

  • 1. A technique for intravenous therapy in patients with scleroderma and in apprehensive children.
    LUNDY JS
    AMA Arch Derm; 1959 Aug; 80(2):226-7. PubMed ID: 13669755
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of scleroderma with the new chelating agent, edathamil.
    MULLER SA; BRUNSTING LA; WINKELMANN RK
    AMA Arch Derm; 1959 Aug; 80(2):187-94. PubMed ID: 13669744
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the therapy of systematized scleropathy (progressive scleroderma) and systematized sarcoidosis with the chelating agent Na2EDTA].
    LANGHOF H; ZABEL H
    Dtsch Gesundheitsw; 1962 Feb; 17():188-97. PubMed ID: 14462154
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progressive scleroderma with considerable electromyographical changes treated with chelating agents (E.D.T.A.)].
    da FONSECA
    J Med (Oporto); 1960 Feb; 41():469-76. PubMed ID: 13823810
    [No Abstract]   [Full Text] [Related]  

  • 5. [1st therapeutic trials of "chelating agents" (EDTA) in cases of scleroderma and of other fibrosclerotic processes of the dermal connective tissues].
    AGOSTINI A; ZANCA A
    G Ital Dermatol; 1961; 102():85-106. PubMed ID: 13859615
    [No Abstract]   [Full Text] [Related]  

  • 6. Edathamil in the treatment of scleroderma and calcinosis cutis.
    WINDER PR; CURTIS AC
    Arch Dermatol; 1960 Nov; 82():732-6. PubMed ID: 13785770
    [No Abstract]   [Full Text] [Related]  

  • 7. Scleroderma. An evaluation of treatment with disodium edetate.
    NELDNER KH; WINKELMANN RK; PERRY HO
    Arch Dermatol; 1962 Sep; 86():305-9. PubMed ID: 14478876
    [No Abstract]   [Full Text] [Related]  

  • 8. Scleroderma (acrosclerosis). II. Tryptophan metabolism before and during treatment by Chelaton (EDTA).
    PRICE JM; BROWN RR; RUKAVINA JG; MENDELSON C; JOHNSON SA
    J Invest Dermatol; 1957 Oct; 29(4):289-98. PubMed ID: 13491892
    [No Abstract]   [Full Text] [Related]  

  • 9. Scleroderma (acrosclerosis). I. Treatment of three cases of the non-calcific variety by Chelation (EDTA).
    RUKAVINA JG; MENDELSON C; PRICE JM; BROWN RR; JOHNSON SA
    J Invest Dermatol; 1957 Oct; 29(4):273-88. PubMed ID: 13491891
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic sclerosis. Fourteen cases treated with chelation (disodium EDTA) and/or pyridoxine, with comments on the possible role of altered tryptophan metabolism in pathogenesis.
    BIRK RE; RUPE CE
    Henry Ford Hosp Med Bull; 1962 Dec; 10():523-53. PubMed ID: 13968436
    [No Abstract]   [Full Text] [Related]  

  • 11. [On therapeutic problems in scleroderma].
    MIENICKI M; KOSSAKOWSKA H
    Przegl Dermatol; 1961; 48(Suppl)():267-72. PubMed ID: 14473576
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of progressive scleroderma].
    WEISENBERG G
    Z Haut Geschlechtskr; 1952 Mar; 12(5):203-10. PubMed ID: 14951474
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic effect of penicillin in scleroderma].
    SELENYI A
    Borgyogy Venerol Sz; 1956 Mar; 10(2):93. PubMed ID: 13315539
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ultrasonic therapy of scleroderma].
    ETTL H
    Strahlentherapie; 1952; 87(4):567-74. PubMed ID: 14950553
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of hyaluronidase in scleroderma.
    CLAESSON U; LINDQUIST B
    Acta Paediatr (Stockh); 1953 May; 42(3):278-81. PubMed ID: 13079763
    [No Abstract]   [Full Text] [Related]  

  • 16. Relaxin (releasin) therapy in diffuse progressive scleroderma; a preliminary report.
    EVANS JA
    AMA Arch Derm; 1959 Feb; 79(2):150-8. PubMed ID: 13616712
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of relaxin in the treatment of scleroderma.
    CASTEN GG; BOUCEK RJ
    J Am Med Assoc; 1958 Jan; 166(4):319-24. PubMed ID: 13491339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of aureomycin in scleroderma; report of 3 cases].
    MEYER DE SCHMID JJ
    Bull Soc Fr Dermatol Syphiligr; 1951; 58(5):570-1. PubMed ID: 14925764
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyaluronidase in scleroderma].
    JOHANSSON S; MOLLER F
    Nord Med; 1957 Jul; 58(30):1086-9. PubMed ID: 13465029
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of diffuse progressive scleroderma.
    EVANS JA; RUBITSKY HJ; PERRY AW
    J Am Med Assoc; 1953 Mar; 151(11):891-9. PubMed ID: 13022338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.